Table 2.
peptide/metal | HC50 (μM) | n | fold increase in toxicity |
---|---|---|---|
Mastoparan X (apo) | 119 ± 4 | 1.6 ± 0.1 | |
Mst-HH: | |||
apo | 295 ± 17 | 1.4 ± 0.1 | |
300 μM Zn(II) added | 38 ± 2 | 1.9 ± 0.2 | 8 |
300 μM Ni(II) added | 33 ± 2 | 1.3 ± 0.1 | 9 |
Mst-EH: | |||
apo* | 250 ± 28 | 2.2 ± 0.6 | |
300 μM Zn(II) added | 81 ± 3 | 2.1 ± 0.1 | 3 |
300 μM Ni(II) added | 273 ± 6 | 2.2 ± 0.1 | |
Mst-HAH: | |||
apo | 69 ± 5 | 1.9 ± 0.2 | |
300 μM Zn(II) added | 119 ± 10 | 1.0 ± 0.1 | |
300 μM Ni(II) added | 6.7 ± 0.7 | 1.8 ± 0.7 | 10 |